Clinical efficacy of triamcinolone acetonide combined with tanshinone ⅡA injection in the treatment of OSF and the effect on serum TGF-β1 and IL-6 / 国际检验医学杂志
International Journal of Laboratory Medicine
; (12): 917-921, 2018.
Article
em Zh
| WPRIM
| ID: wpr-692771
Biblioteca responsável:
WPRO
ABSTRACT
Objective To investigate the effects of triamcinolone acetonide combined with tanshinone ⅡA (Monomer of tanshinone)injection on oral submucous fibrosis(OSF)and the effect of serum TGF-β1 and IL-6 on patients.Methods 92 patients with OSF,w ho came to the hospital for treatment from April 2013 to April 2016,were selected and randomly divided into control group(46 cases)and experimental group(46 ca-ses).They were respectively treated with triamcinolone acetonide and triamcinolone acetonide combined with tanshinone injection.The two groups were treated for 3 courses and were followed up for 12 months.The VAS scores and mouth opening were compared between the two groups before the treatment and 2,4,6,and 12 months after the treatment,The serum TGF-β1,IL-6,lesion area and the changes of quality of life oral health impact scale(OHIP-14)scores of two groups were compared before and after treatment.Results 6 months after follow-up,the maximum mouth opening of the two groups was significantly increased than that before treatment,and improvement speed and improvement degree of the experimental group were better than those of the control group(P<0.05).After 2,4,6 and 12 months follow-up,the VAS scores of the two groups were significantly lower than those before treatment,and the experimental group were significantly lower than those of the control group(P<0.05),but the VAS score of two groups after 12 months increased than that after 6 months,and the control group was more obvious(P<0.05).After treatment,the levels of TGF-β1 and IL-6 of the experimental group were significantly lower than those of the control group and before the treat-ment(P<0.05);After treatment,the lesion area of the experimental group was significantly lower than that of the control group,and the OHIP-14 score was significantly higher than that of the control group,and the difference was significant compared with this group before treatment(P<0.05).Conclusion The local injec-tion treatment of triamcinolone and tanshinone injection has godd efficacy of OSF patients,and significantly re-duces the levels of TGF-β1 and IL-6 in serum.
Texto completo:
1
Base de dados:
WPRIM
Aspecto:
Patient_preference
Idioma:
Zh
Revista:
International Journal of Laboratory Medicine
Ano de publicação:
2018
Tipo de documento:
Article